4//SEC Filing
INDEVUS PHARMACEUTICALS INC 4
Accession 0001209191-09-016769
CIK 0000854222operating
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 3:01 PM ET
Size
12.0 KB
Accession
0001209191-09-016769
Insider Transaction Report
Form 4
ENDO PHARMACEUTICALS HOLDINGS INC
10% Owner
Transactions
- Purchase
Common Stock, par value $.001 per share
2009-03-17+287,810→ 70,220,262 total - Purchase
Common Stock, par value $.001 per share
2009-03-13+462,145→ 66,632,354 total - Purchase
Common Stock, par value $.001 per share
2009-03-16+3,300,098→ 69,932,452 total
BTB Purchaser Inc.
10% Owner
Transactions
- Purchase
Common Stock, par value $.001 per share
2009-03-17+287,810→ 70,220,262 total - Purchase
Common Stock, par value $.001 per share
2009-03-13+462,145→ 66,632,354 total - Purchase
Common Stock, par value $.001 per share
2009-03-16+3,300,098→ 69,932,452 total
Footnotes (5)
- [F1]On February 23, 2009, Endo and Purchaser announced the commencement of a subsequent offering period, during which these Shares were tendered and accepted for payment. Certain of the Shares tendered during the subsequent offering period were previously delivered through notices of guaranteed delivery during the tender offer.
- [F2]Pursuant to the terms of the Agreement & Plan of Merger, dated as of Jan. 5, 2009, by and among Endo Pharmaceuticals Holdings Inc. ("Endo"), BTB Purchaser Inc. ("BTB") and Indevus Pharmaceuticals, Inc. ("Indevus"), Endo (through BTB) commenced a cash tender offer to purchase all of the issued and outstanding shares fo the common stock of Indevus (the "Shares") at a price of $4.50 per share, without interest, plus contractual rights to receive up to an additional $3.00 per Share in contingent cash consideration payments. The initial tender offer period expired at 5:00 p.m.(ET), Fri., Feb. 20, 2009, at which time approximately 55,008,149 Shares had been validly tendered and not withdrawn pursuant to the tender offer and such Shares were accepted for purchase by the Purchaser on Feb. 23, 2009; such number represents the number of Shares in which the Reporting Person has a beneficial interest as of that date.
- [F3]The Shares purchased represent approximately 83.840% of Indevus' outstanding Shares.
- [F4]The Shares purchased represent approximately 87.992% of Indevus' outstanding Shares.
- [F5]The Shares purchased represent approximately 88.355% of Indevus' outstanding Shares.
Documents
Issuer
INDEVUS PHARMACEUTICALS INC
CIK 0000854222
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000854222
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 3:01 PM ET
- Size
- 12.0 KB